LAT1 SELECTIVE INHIBITORS FOR USE IN THE TREATMENT OF ADVERSE VENTRICULAR -REMODELLING AND OF HEART FAILURE

The present disclosure relates to LAT1 selective inhibitors for use in the prophylactic or the therapeutic treatment of adverse ventricular remodelling or of heart failure. It also relates to drug combinations of a LAT1 inhibitor and other drugs addressed to the treatment of adverse ventricular remo...

Full description

Saved in:
Bibliographic Details
Main Authors DELGADO TOMÀS, Sara, ALUJA GONZÁLEZ, David, FERREIRA GONZÁLEZ, Ignacio, INSERTE IGUAL, Javier, BARRABÉS RIU, José Antonio
Format Patent
LanguageEnglish
French
German
Published 30.04.2025
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to LAT1 selective inhibitors for use in the prophylactic or the therapeutic treatment of adverse ventricular remodelling or of heart failure. It also relates to drug combinations of a LAT1 inhibitor and other drugs addressed to the treatment of adverse ventricular remodelling and of heart failure, as well as to pharmaceutical compositions and kits containing them, and to the use of the latter in for any one of the mentioned treatments.
Bibliography:Application Number: EP20230383082